i'm not blaming management. just curious how something that was mentioned on a couple the calls as a potential catalyst it's just gone. maybe after the FDA letter, our management is just gun shy of mentioning anything other than official trial results - which i can understand.

anyway, i guess it's a dead issue at this point - and hopefully the patients did indeed benefit from the drug and it helped them, whether we ever know or not.